Cenduit is a leading IRT systems specialist that focuses on accelerating clinical trials through quality, flexibility, and expertise. Founded in 2007, the company offers rapid study startup software, clinical supply chain intelligence, and patient randomization and trial supply management (RTSM). With a global presence, including over 500 experts worldwide in the US, UK, Switzerland, India, Japan, and China, Cenduit has extensive clinical trial experience in more than 100 countries, interacting with over 600,000 patients at more than 32,000 sites. Their services also encompass integration, patient engagement, and materials forecasting. The company's slogan, "Accelerating clinical trials through: Quality, Flexibility & Expertise," reflects their commitment to ensuring studies start quickly and run smoothly. With a focus on Biotechnology, Health Care, and Information Technology, Cenduit aims to meet study needs on time and within budget. Currently, there is no publicly available information on their last investment and investors.
There is no investment information
No recent news or press coverage available for Cenduit.